Florida Cancer Specialists: Bringing Telemedicine to Oncology Practice in COVID-19

Experts from Florida Cancer Specialists cover how the COVID-19 pandemic is transforming telemedicine in oncology by addressing billing, operations, training and provider perspectives in this webinar presented on Monday, April 20, 2020.

Related Videos

Related Content

Advertisement

May 21st 2025

The Role of Pharmacists Expands Beyond Dispensing for Novel Cancer Therapies: Eileen Peng, PharmD

Laura Joszt, MA Eileen Peng, PharmD

The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is transforming the role of pharmacists in enhancing patient care.

May 20th 2025

Mental Health Awareness: Transforming Workplace Support and Engagement

Giuliana Grossi Jim Kinville

Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.

May 21st 2025

ASCO, Google Cloud Launch AI-Powered Tool to Help Doctors Access Guidelines

Mary Caffrey

The artificial intelligence-powered assistant will save clinicians time, especially in busy settings in community oncology.

May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.

May 21st 2025

“A Different Way of Looking at How You Can Age in America”

Mary Caffrey

SCAN Group takes ownership of an integrated care delivery organization, to expand its impact on the lives of vulnerable seniors.

May 20th 2025

Mepolizumab Reduces COPD Exacerbations in Patients With Eosinophilic Inflammation

Hayden E. Klein

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of life in patients with eosinophilic chronic obstructive pulmonary disease (COPD).

Related Content

Advertisement

May 21st 2025

The Role of Pharmacists Expands Beyond Dispensing for Novel Cancer Therapies: Eileen Peng, PharmD

Laura Joszt, MA Eileen Peng, PharmD

The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is transforming the role of pharmacists in enhancing patient care.

May 20th 2025

Mental Health Awareness: Transforming Workplace Support and Engagement

Giuliana Grossi Jim Kinville

Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.

May 21st 2025

ASCO, Google Cloud Launch AI-Powered Tool to Help Doctors Access Guidelines

Mary Caffrey

The artificial intelligence-powered assistant will save clinicians time, especially in busy settings in community oncology.

May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.

May 21st 2025

“A Different Way of Looking at How You Can Age in America”

Mary Caffrey

SCAN Group takes ownership of an integrated care delivery organization, to expand its impact on the lives of vulnerable seniors.

May 20th 2025

Mepolizumab Reduces COPD Exacerbations in Patients With Eosinophilic Inflammation

Hayden E. Klein

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of life in patients with eosinophilic chronic obstructive pulmonary disease (COPD).